VivoSim Labs, INC. (VIVS)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue TTM

0 2M 4M 6M Q2 '17: 3.1M Q3 '17: 4M Q4 '17: 4.2M Q1 '18: 4.3M Q2 '18: 4.3M Q3 '18: 4.3M Q4 '18: 4.6M Q1 '19: 4.3M Q2 '19: 3.9M Q3 '19: 3.5M Q4 '19: 3.1M Q1 '20: 3.1M Q2 '20: 3.4M Q3 '20: 2.9M Q4 '20: 2.2M Q1 '21: 1.5M Q2 '21: 298K Q3 '21: 0 Q4 '21: 0 Q1 '22: 0 Q2 '22: 0 Q3 '22: 0 Q4 '22: 1.5M Q1 '23: 1.5M Q2 '23: 1.6M Q3 '23: 1.7M Q4 '23: 370K Q1 '24: 445K Q2 '24: 368K Q3 '24: 242K Q4 '24: 109K Q1 '25: 73K Q2 '25: 103K Q3 '25: 122K Q4 '25: 144K Q1 '26: 142K Q2 '26: 140K Q3 '26: 142K Q4 '26: 131K Q1 '27: 112K Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Gross Profit TTM

0 1.5M 3M 4.5M Q4 '18: 3.6M Q1 '19: 3.5M Q2 '19: 3.2M Q3 '19: 2.9M Q4 '19: 2.6M Q1 '20: 2.7M Q2 '20: 2.8M Q3 '20: 2.4M Q4 '20: 1.9M Q1 '21: 1.3M Q2 '21: 285K Q3 '21: 0 Q4 '21: 0 Q4 '25: 139K Q1 '26: 139K Q2 '26: 138K Q3 '26: 142K Q4 '26: 131K Q2 '19 Q1 '20 Q4 '20 Q3 '21 Q1 '26 Q4 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-45M -30M -15M 0 15M 30M 45M Q2 '17: -37.2M Q3 '17: -36.3M Q4 '17: -38.6M Q1 '18: -40M Q2 '18: -40.1M Q3 '18: -38.4M Q4 '18: -35.3M Q1 '19: -32.6M Q2 '19: -29.1M Q3 '19: -27.7M Q4 '19: -27.3M Q1 '20: -26.2M Q2 '20: -27M Q3 '20: -25.7M Q4 '20: -21.5M Q1 '21: -17.7M Q2 '21: -19.9M Q3 '21: -17.1M Q4 '21: -16.8M Q1 '22: -16.6M Q2 '22: -11.2M Q3 '22: -12.2M Q4 '22: -11.5M Q1 '23: -12.2M Q2 '23: -12M Q3 '23: -11.9M Q4 '23: -17.7M Q1 '24: -18.7M Q2 '24: -19.4M Q3 '24: -19.8M Q4 '24: -15.1M Q1 '25: -14.3M Q2 '25: -12.8M Q3 '25: -12.6M Q4 '25: -12.6M Q1 '26: -12.1M Q2 '26: -12.2M Q3 '26: -11.5M Q4 '26: -11.5M Q1 '27: -11.3M Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Net Income TTM

-45M -30M -15M 0 15M 30M 45M Q2 '17: -37M Q3 '17: -36.2M Q4 '17: -38.4M Q1 '18: -39.8M Q2 '18: -39.8M Q3 '18: -38M Q4 '18: -34.8M Q1 '19: -32.1M Q2 '19: -28.5M Q3 '19: -27.1M Q4 '19: -26.6M Q1 '20: -25.5M Q2 '20: -26M Q3 '20: -23M Q4 '20: -18.7M Q1 '21: -15.2M Q2 '21: -17.8M Q3 '21: -17M Q4 '21: -16.8M Q1 '22: -16.6M Q2 '22: -11.1M Q3 '22: -12.1M Q4 '22: -11.4M Q1 '23: -12.1M Q2 '23: -11.9M Q3 '23: -11.7M Q4 '23: -17.3M Q1 '24: -18.1M Q2 '24: -18.7M Q3 '24: -19.1M Q4 '24: -14.7M Q1 '25: -14M Q2 '25: -12.5M Q3 '25: -12.4M Q4 '25: -2.5M Q1 '26: -2M Q2 '26: -2M Q3 '26: -1.2M Q4 '26: -13.8M Q1 '27: -12.3M Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Cost of Revenue TTM

0 400K 800K 1.2M Q4 '16: 0 Q1 '17: 168K Q2 '17: 561K Q3 '17: 773K Q4 '17: 956K Q1 '18: 1.1M Q2 '18: 950K Q3 '18: 930K Q4 '18: 1M Q1 '19: 849K Q2 '19: 720K Q3 '19: 664K Q4 '19: 482K Q1 '20: 413K Q2 '20: 552K Q3 '20: 429K Q4 '20: 328K Q1 '21: 277K Q2 '21: 13K Q3 '21: 0 Q4 '21: 0 Q4 '25: 5K Q1 '26: 3K Q2 '26: 2K Q3 '26: 0 Q4 '26: 0 Q1 '17 Q1 '18 Q1 '19 Q1 '20 Q1 '21 Q4 '25 Q4 '26

Operating Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q2 '17: -29.4M Q3 '17: -29.5M Q4 '17: -29.2M Q1 '18: -31.3M Q2 '18: -31.1M Q3 '18: -30.5M Q4 '18: -28.9M Q1 '19: -25.2M Q2 '19: -23.4M Q3 '19: -20.9M Q4 '19: -20.4M Q1 '20: -19.3M Q2 '20: -20.1M Q3 '20: -16.8M Q4 '20: -14.9M Q1 '21: -11.5M Q2 '21: -13.5M Q3 '21: -14.4M Q4 '21: -13.3M Q1 '22: -12.2M Q2 '22: -7.2M Q3 '22: -9M Q4 '22: -8.5M Q1 '23: -9.5M Q2 '23: -9.5M Q3 '23: -9.2M Q4 '23: -12.4M Q1 '24: -15.3M Q2 '24: -16.2M Q3 '24: -16.7M Q4 '24: -14.7M Q1 '25: -12.3M Q2 '25: -11.8M Q3 '25: -10.1M Q4 '25: -9.5M Q1 '26: -10.4M Q2 '26: -10.2M Q3 '26: -10.6M Q4 '26: -10.8M Q1 '27: -10.1M Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q1 '16: -12.3M Q2 '16: -27.3M Q3 '16: -29.8M Q4 '16: -31.5M Q1 '17: -32.6M Q2 '17: -30.4M Q3 '17: -31M Q4 '17: -30.5M Q1 '18: -32.6M Q2 '18: -32M Q3 '18: -30.9M Q4 '18: -29.1M Q1 '19: -25.4M Q2 '19: -23.6M Q3 '19: -21.1M Q4 '19: -20.5M Q2 '21: -13.5M Q3 '21: -14.7M Q4 '21: -13.7M Q1 '22: -12.8M Q2 '22: -7.8M Q3 '22: -9.5M Q4 '22: -8.9M Q1 '23: -9.7M Q2 '23: -9.9M Q3 '23: -9.5M Q4 '23: -12.8M Q1 '24: -15.6M Q2 '24: -16.5M Q3 '24: -16.9M Q4 '24: -14.7M Q1 '25: -12.4M Q2 '25: -11.8M Q3 '25: -10.1M Q4 '25: -9.5M Q1 '26: -10.4M Q2 '26: -10.2M Q3 '26: -10.6M Q4 '26: -10.8M Q1 '27: -10.1M Q1 '17 Q2 '18 Q3 '19 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '12: 12.3M Q2 '13: 55.8M Q2 '14: 72.7M Q1 '22: 8.7M Q2 '22: 8.7M Q3 '22: 8.7M Q1 '23: 8.7M Q2 '23: 8.7M Q3 '23: 8.7M Q1 '24: 8.7M Q2 '24: 8.7M Q3 '24: 9.1M Q1 '25: 1.2M Q2 '25: 1.5M Q3 '25: 1.5M Q1 '26: 2.5M Q2 '26: 2.6M Q3 '26: 2.6M Q1 '27: 5.2M Q2 '12 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-27.00 -18.00 -9.00 0.00 9.00 18.00 27.00 Q2 '17: -0.39 Q3 '17: -0.37 Q4 '17: -0.38 Q1 '18: -0.39 Q2 '18: -0.38 Q3 '18: -0.36 Q4 '18: -0.33 Q1 '19: -0.30 Q2 '19: -0.26 Q3 '19: -0.25 Q4 '19: -0.24 Q1 '20: -0.22 Q2 '20: -1.17 Q3 '20: -1.71 Q4 '20: -2.05 Q1 '21: -2.40 Q2 '21: -2.76 Q3 '21: -2.53 Q4 '21: -2.43 Q1 '22: -2.32 Q2 '22: -1.36 Q3 '22: -1.39 Q4 '22: -1.31 Q1 '23: -1.39 Q2 '23: -1.37 Q3 '23: -1.34 Q4 '23: -1.97 Q1 '24: -2.06 Q2 '24: -2.14 Q3 '24: -2.17 Q4 '24: -19.26 Q1 '25: -21.54 Q2 '25: -22.76 Q3 '25: -24.64 Q4 '25: -1.70 Q1 '26: -0.10 Q2 '26: 0.60 Q3 '26: 1.85 Q4 '26: -5.36 Q1 '27: -4.47 Q2 '18 Q3 '19 Q4 '20 Q1 '22 Q2 '23 Q3 '24 Q4 '25 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.